Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have RNA binding activity; epidermal growth factor receptor binding activity; and protein C-terminus binding activity. Involved in several processes, including homeostasis of number of cells; neuromuscular process; and neuron differentiation. Localizes to perinuclear region of cytoplasm. Is expressed in several structures, including alimentary system; central nervous system; liver; sensory organ; and spleen. Used to study spinocerebellar ataxia type 2. Human ortholog(s) of this gene implicated in late onset Parkinson's disease and spinocerebellar ataxia type 2. Orthologous to human ATXN2 (ataxin 2).